Who owns ARROWHEAD PHARMACEUTICALS IN NOTE 1/1?
- CUSIP Number: 04280aac4
Tip: Access positions for across all investors
Analyze quarterly positions in Arrowhead Pharmaceuticals In Note 1/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Arrowhead Pharmaceuticals In Note 1/1 stock
Who bought or sold ARROWHEAD PHARMACEUTICALS IN NOTE 1/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 200M | $241M | 0% | Jun 2026 |
|
| Camden Asset Management | 64M | $77M | 41% | Jun 2026 |
|
| LMR Partners | 40M | $48M | 14% | Jun 2026 |
|
| Linden Advisors | 35M | $42M | -62% | Jun 2026 |
|
| Ubs Global Asset Management Americas | 29M | $35M | 100% | Jun 2026 |
|
| Readystate Asset Management | 25M | $30M | 0% | Jun 2026 |
|
| Lazard Asset Management | 25M | $299k | 183% | Jun 2026 |
|
| Calamos Advisors | 22M | $27M | -2% | Jun 2026 |
|
| MacKay Shields | 21M | $24M | 582% | Jun 2026 |
|
| DeepCurrents Investment Group | 19M | $23M | 100% | Jun 2026 |
|
| Context Capital Management | 18M | $22M | 23% | Jun 2026 |
|
| Advent Capital Management | 18M | $21M | 100% | Jun 2026 |
|
| State Street Corporation | 14M | $14M | 100% | Mar 2026 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 12M | $15M | 1115% | Jun 2026 |
|
| Oaktree Capital Management | 9.1M | $11M | -17% | Jun 2026 |
|
| Balyasny Asset Management | 8.5M | $10M | 100% | Jun 2026 |
|
| Lombard Odier Asset Management | 8.5M | $10M | 100% | Jun 2026 |
|
| Lord, Abbett & Co | 7.3M | $8.7M | 100% | Jun 2026 |
|
| FMR | 7.1M | $8.5M | -1% | Jun 2026 |
|
| Citadel Advisors | 7.1M | $8.5M | 100% | Jun 2026 |
|
| SSI Investment Management | 6.6M | $7.9M | 0% | Jun 2026 |
|
| Shenkman Capital Management | 5.8M | $7.0B | -34% | Jun 2026 |
|
| Weiss Asset Management LP[1 | 5.0M | $6.0M | 100% | Jun 2026 |
|
| State of Wisconsin Investment Board | 4.0M | $4.8M | 33% | Jun 2026 |
|
| Citigroup | 3.5M | $3.6M | 100% | Mar 2026 |
|
| Millennium Management | 3.1M | $3.8M | -7% | Jun 2026 |
|
| Amundi | 3.1M | $3.7M | 0% | Jun 2026 |
|
| Toronto-Dominion Bank | 3.1M | $3.7M | 221% | Jun 2026 |
|
| Bank of America Corporation | 2.7M | $3.2M | 436% | Jun 2026 |
|
| Agf Management | 2.3M | $2.7M | 80% | Jun 2026 |
|
| Tenor Capital Management | 2.0M | $2.4M | 0% | Jun 2026 |
|
| Invesco | 2.0M | $2.4M | -38% | Jun 2026 |
|
| Man Group | 1.8M | $2.1M | 90% | Jun 2026 |
|
| Acasta Partners UK | 1.5M | $1.8M | 275% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.4M | $1.7M | -90% | Jun 2026 |
|
| RWC Asset Management | 1.3M | $1.6M | -5% | Jun 2026 |
|
| Bank of New York Mellon | 1.1M | $1.3M | -8% | Jun 2026 |
|
| Groupama Asset Managment | 1.0M | $1.2M | 0% | Jun 2026 |
|
| Wells Fargo & Company | 885k | $1.1M | 3% | Jun 2026 |
|
| Kohlberg Kravis Roberts & Co | 800k | $958k | 0% | Jun 2026 |
|
| Morgan Stanley | 695k | $719k | 100% | Mar 2026 |
|
| Central Pacific Bank - Trust Division | 342k | $408k | 100% | Jun 2026 |
|
| Sei Investments | 200k | $239k | 525% | Jun 2026 |
|
| Russell Investments | 182k | $219k | 100% | Jun 2026 |
|
| UBS Group | 152k | $181k | -96% | Jun 2026 |
|
| Oppenheimer Asset Management | 103k | $123k | 100% | Jun 2026 |
|
| Ares Systematic Credit | 100k | $120k | -90% | Jun 2026 |
|
| Calamos Wealth Management | 87k | $105k | 100% | Jun 2026 |
|
| Loomis, Sayles and | 66k | $5.3M | -62% | Jun 2026 |
|
| Stephens | 33k | $39k | 100% | Jun 2026 |
|
| SG Americas Securities | 29k | $3.5M | 322% | Jun 2026 |
|
| ADAR1 Capital Management | 10k | $1.2M | 0% | Jun 2026 |
|
Who sold out of Arrowhead Pharmaceuticals In Note 1/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jump Financial | Mar 2026 | 19M | $19M |
| Polar Securities | Mar 2026 | 10M | $10M |
| Point72 Asset Management | Mar 2026 | 7.8M | $8.1M |
| Ing Investment Management | Mar 2026 | 5.3M | $5.5M |
| Goldman Sachs Group | Mar 2026 | 3.0M | $3.1M |
| Braidwell | Mar 2026 | 2.3M | $2.3M |
| Gabelli Funds | Mar 2026 | 2.1M | $2.3M |
| Franklin Resources | Mar 2026 | 1.7M | $1.7M |
| Jane Street | Mar 2026 | 1.5M | $1.6M |
| Davidson Kempner Capital Management | Mar 2026 | 1.0M | $1.0M |
| Nomura Holdings | Mar 2026 | 14k | $875k |